Skip to main content
Log in

Actinium-225-PSMA-imaging-and-therapy/Lutetium-177-PSMA-imaging-and-therapy

Thrombocytopenia, lack of efficacy following compassionate use

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Sheikh G, et al. Systematic evaluation of response and adverse events in mCRPC patients treated with different combinations of 225Ac/177Lu-PSMA-therapy. European Journal of Nuclear Medicine and Molecular Imaging 50 (Suppl. 1): S325, Jan 2023. Available from: URL: https://dx.doi.org/10.1007/s00259-023-06333-x [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Actinium-225-PSMA-imaging-and-therapy/Lutetium-177-PSMA-imaging-and-therapy. Reactions Weekly 1986, 17 (2023). https://doi.org/10.1007/s40278-023-51322-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-51322-7

Navigation